
Opinion|Videos|May 21, 2025
Q&A: Resources and Legislative Advocacy for Point-of-Care Testing
Author(s)Duane Jones, BS Pharm
A panelist discusses how developing relationships with legislators and presenting data on health care cost savings can help pass legislation supporting pharmacist-provided clinical services, including point-of-care testing.
Advertisement
Episodes in this series

Q&A – Staff Training and Legislative Advocacy
Main Discussion Topics:
- Resources for point-of-care testing staff training
- Legislative advocacy strategies for pharmacy practice expansion
- Expansion to additional clinical services (contraceptive prescribing)
Key Points for Physicians:
- CPESN provides valuable resources for protocol development
- Developing relationships with state legislators supports practice expansion initiatives
- Pharmacy-based testing can lead to expanded clinical service opportunities
Notable Insights:
- Data demonstrating cost savings (15% reduction in emergency department visits, 30% reduction in hospitalizations) supports legislative advocacy
- Building relationships with local legislators through personal meetings is more effective than general advocacy
- Initial point-of-care testing implementation often leads to additional clinical service opportunities
Clinical Significance:
Strategic advocacy efforts highlighting health care access improvements and cost savings potential can support legislative changes enabling pharmacy practice expansion. This ultimately creates sustainable health care access points in underserved communities.
Advertisement
Related to this article

Detailed phase 3 data show retatrutide lowered body weight and A1C over 80 weeks for patients with diabetes and obesity.

In celebration of the organization’s recent convention, NCPA released its annual digest report for members, providing a detailed overview of independent community pharmacy.

Local collaborations can turn pharmacies into care-coordination hubs, but lasting results require trained teams, shared data, and sustainable payment.

In a rapidly evolving diabetes and obesity management landscape, Brian Smith, PharmD, discusses approaches that are helping patients maximize their outcomes on GLP-1 therapy.

A structured recommendation workflow at a community pharmacy was associated with more multivaccine patients than routine practice.

In part 2 of our pre-election series, detailing key health policies for pharmacists at this year’s midterms, a legal expert touches on MFN pricing, ACA subsidies, and more.

Pharmacists can improve cardiometabolic adherence by easing adverse effects, simplifying regimens, tackling costs, and synchronizing refills.
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacist Protocol Is Linked With More Same-Day Vaccine Coadministration
2
FAQ: Policies for Pharmacists to Track Heading into 2026 Midterms
3
Cost-Plus Pricing Reshapes Pharmacy, But Savings Are Not Guaranteed
4
Integrated Care and the Keys to Successful GLP-1 Therapy
5


